TheraRadar
Clinical-Stage Companies / Hanmi Pharmaceutical Company Limited

Hanmi Pharmaceutical Company Limited

Pre-Approval PRO BETA
158
Total Trials
32
Phase 3
22
Phase 2
11
Recruiting
992
Score

Pipeline by Phase

Phase 3
32
Phase 2
22
Phase 1
102

Therapeutic Focus

Healthy Hypertension Diabetes Mellitus Obesity Erectile Dysfunction

Clinical Trials (158)

NCT06174766 Phase 3 RECRUITING

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

Started: 5/10/2024

NCT07379333 Phase 3 NOT YET RECRUITING

A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Started: 2/1/2026

NCT06595004 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients

Started: 11/22/2024

NCT06174779 Phase 3 ACTIVE NOT RECRUITING

A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

Started: 1/3/2024

NCT06438172 Phase 3 COMPLETED

A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension

Started: 3/25/2024

NCT05656092 Phase 3 COMPLETED

A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

Started: 3/6/2023

NCT05450601 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients

Started: 9/1/2022

NCT05362110 Phase 3 COMPLETED

A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension

Started: 5/16/2022

NCT04830449 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients

Started: 10/29/2020

NCT04820907 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients

Started: 10/27/2020

NCT05199129 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients

Started: 11/17/2021

NCT04325620 Phase 3 COMPLETED

Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease

Started: 6/10/2019

NCT05024721 Phase 3 COMPLETED

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis

Started: 8/9/2021

NCT03353350 Phase 3 COMPLETED

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise

Started: 12/5/2017

NCT04652349 Phase 3 COMPLETED

Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

Started: 7/6/2020

NCT04080726 Phase 3 COMPLETED

Efficacy and Safety of HIP1601 Capsule

Started: 10/25/2018

NCT04074551 Phase 3 COMPLETED

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Started: 7/16/2019

NCT04324918 Phase 3 COMPLETED

Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis

Started: 10/23/2018

NCT02587988 Phase 3 COMPLETED

Trial to Evaluate the Efficacy and Safety of HCP1302

Started: 9/1/2014

NCT02916602 Phase 3 COMPLETED

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Started: 4/1/2015

NCT02899455 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

Started: 7/1/2014

NCT02667938 Phase 3 COMPLETED

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Started: 3/1/2015

NCT02390882 Phase 3 COMPLETED

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Started: 10/1/2014

NCT00940667 Phase 3 COMPLETED

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

Started: 5/1/2008

NCT01872182 Phase 3 TERMINATED

Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome

Started: 5/1/2013

NCT02205606 Phase 3 COMPLETED

Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia

Started: 6/1/2014

NCT02552667 Phase 3 COMPLETED

Efficacy and Safety of HCP1102 Capsule

Started: 9/1/2014

NCT01442987 Phase 3 COMPLETED

Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Started: 5/1/2011

NCT01509209 Phase 3 COMPLETED

Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis

Started: 5/1/2011

NCT01640535 Phase 3 COMPLETED

Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients

Started: 6/1/2012

NCT01127217 Phase 3 COMPLETED

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

Started: 5/1/2009

NCT00940680 Phase 3 COMPLETED

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

Started: 4/1/2008

NCT07449754 Phase 2 RECRUITING

Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma

Started: 2/12/2026

NCT04775706 Phase 2 RECRUITING

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Started: 3/3/2022

NCT04732416 Phase 2 RECRUITING

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

Started: 5/5/2022

NCT07527650 Phase 2 NOT YET RECRUITING

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Started: 5/1/2026

NCT07205900 Phase 2 ACTIVE NOT RECRUITING

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

Started: 12/2/2025

NCT04505436 Phase 2 ACTIVE NOT RECRUITING

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Started: 7/31/2020

NCT04768686 Phase 2 COMPLETED

FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer

Started: 5/18/2021

NCT04959305 Phase 2 COMPLETED

A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension

Started: 4/22/2021

NCT03897868 Phase 2 COMPLETED

A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension

Started: 3/21/2019

NCT02418689 Phase 2 COMPLETED

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

Started: 4/1/2015

NCT02485652 Phase 2 TERMINATED

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Started: 8/31/2015

NCT04044170 Phase 2 TERMINATED

Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

Started: 7/30/2019

NCT02444819 Phase 2 COMPLETED

Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy

Started: 3/1/2015

NCT02057172 Phase 2 COMPLETED

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Started: 1/1/2014

NCT02081118 Phase 2 COMPLETED

Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Started: 2/1/2014

NCT01452451 Phase 2 COMPLETED

Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

Started: 12/1/2011

NCT02075281 Phase 2 COMPLETED

Effect of LAPS-Exendin on Body Weight in Obese Population

Started: 2/1/2014

NCT01822340 Phase 2 COMPLETED

Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients

Started: 10/1/2011

NCT01806818 Phase 2 COMPLETED

Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

Started: 2/1/2013

NCT01505777 Phase 2 COMPLETED

Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea

Started: 5/1/2011

NCT06234397 Phase 1 RECRUITING

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Started: 12/28/2023

NCT07219589 Phase 1 RECRUITING

A Single Ascending Dose Study of HM17321 in Healthy Adult Participants

Started: 11/6/2025

NCT06724016 Phase 1 RECRUITING

Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors

Started: 12/11/2024

NCT05598151 Phase 1 RECRUITING

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Started: 1/11/2023

NCT07297693 Phase 1 NOT YET RECRUITING

A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers

Started: 12/19/2025

NCT06481098 Phase 1 COMPLETED

A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.

Started: 5/28/2024

NCT05711381 Phase 1 COMPLETED

Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function

Started: 12/2/2022

NCT06518122 Phase 1 COMPLETED

A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers

Started: 9/1/2024

NCT04076293 Phase 1 COMPLETED

Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects

Started: 10/8/2019

NCT03374241 Phase 1 COMPLETED

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)

Started: 4/4/2018

NCT04032782 Phase 1 COMPLETED

A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects

Started: 10/2/2018

NCT03744182 Phase 1 COMPLETED

A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

Started: 11/1/2018

NCT04167553 Phase 1 COMPLETED

Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

Started: 8/30/2019

NCT05407220 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.

Started: 6/29/2022

NCT06346184 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers

Started: 5/2/2024

NCT06357910 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

Started: 5/17/2024

NCT05737082 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers

Started: 3/30/2023

NCT04324905 Phase 1 COMPLETED

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers

Started: 4/29/2020

NCT04975711 Phase 1 COMPLETED

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers

Started: 7/12/2021

NCT05862090 Phase 1 COMPLETED

A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers

Started: 4/5/2023

NCT05481307 Phase 1 COMPLETED

A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203

Started: 8/2/2022

NCT05548387 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers

Started: 9/2/2022

NCT05155995 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers

Started: 9/28/2021

NCT05548543 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

Started: 10/17/2022

NCT05723549 Phase 1 COMPLETED

A Study to Evaluate the PK, Safety and Tolerability of HCP1803.

Started: 2/2/2023

NCT03089112 Phase 1 COMPLETED

Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501

Started: 3/31/2017

NCT04204629 Phase 1 COMPLETED

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects

Started: 1/13/2020

NCT04946903 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008

Started: 6/10/2021

NCT04762407 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903

Started: 11/20/2020

NCT03826641 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

Started: 2/1/2019

NCT05191563 Phase 1 COMPLETED

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

Started: 7/31/2021

NCT04967014 Phase 1 COMPLETED

Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers

Started: 5/6/2021

NCT03332836 Phase 1 TERMINATED

Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

Started: 10/25/2017

NCT04764201 Phase 1 COMPLETED

The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers

Started: 1/16/2021

NCT04510415 Phase 1 TERMINATED

Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI

Started: 3/29/2018

NCT03330314 Phase 1 COMPLETED

Molar Potency Study of HM12460A in Healthy Subjects

Started: 10/24/2017

NCT03118817 Phase 1 COMPLETED

Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers

Started: 5/19/2017

NCT02405065 Phase 1 COMPLETED

Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573

Started: 1/12/2015

NCT04322266 Phase 1 COMPLETED

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

Started: 12/21/2018

NCT04252872 Phase 1 COMPLETED

Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers

Started: 8/1/2015

NCT04087525 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects

Started: 10/23/2018

NCT04084197 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.

Started: 12/19/2018

NCT04084184 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects

Started: 3/15/2019

NCT04081844 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

Started: 5/3/2018

NCT04081857 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects

Started: 6/3/2019

NCT03882112 Phase 1 COMPLETED

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects

Started: 4/17/2019

NCT04039724 Phase 1 COMPLETED

Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

Started: 2/1/2015

NCT01588145 Phase 1 COMPLETED

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

Started: 3/1/2012

NCT03371849 Phase 1 COMPLETED

PK and Safety Study of HCP1102, HGP0813 and HGP1408

Started: 7/19/2017

NCT02302443 Phase 1 COMPLETED

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470

Started: 1/1/2015

NCT01724814 Phase 1 COMPLETED

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A

Started: 12/20/2012

NCT03330327 Phase 1 COMPLETED

Molar Potency Study of HM12470 in Healthy Subjects

Started: 3/30/2015

NCT01894399 Phase 1 COMPLETED

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

Started: 9/1/2013

NCT02941796 Phase 1 COMPLETED

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

Started: 6/1/2016

NCT01864863 Phase 1 COMPLETED

To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Started: 4/1/2013

NCT02941731 Phase 1 COMPLETED

Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions

Started: 4/1/2015

NCT02941848 Phase 1 COMPLETED

Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers

Started: 11/1/2014

NCT02940314 Phase 1 COMPLETED

Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers

Started: 3/1/2016

NCT02243319 Phase 1 COMPLETED

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

Started: 9/1/2014

NCT02473900 Phase 1 COMPLETED

Evaluating the Bioequivalence of HIP1403, HGP0919

Started: 4/1/2015

NCT02529800 Phase 1 COMPLETED

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

Started: 9/1/2015

NCT02545829 Phase 1 COMPLETED

Evaluating the Bioequivalence of HIP1302, HGP1406

Started: 8/1/2015

NCT01514903 Phase 1 COMPLETED

Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Started: 12/1/2011

NCT02127320 Phase 1 COMPLETED

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

Started: 6/1/2014

NCT02715401 Phase 1 COMPLETED

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

Started: 10/1/2015

NCT02712411 Phase 1 COMPLETED

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

Started: 7/1/2015

NCT01746771 Phase 1 COMPLETED

A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer

Started: 11/1/2012

NCT02554136 Phase 1 COMPLETED

Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816

Started: 7/1/2015

NCT02387554 Phase 1 COMPLETED

Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

Started: 8/1/2014

NCT01765478 Phase 1 COMPLETED

Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers

Started: 1/1/2013

NCT01463982 Phase 1 COMPLETED

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Started: 12/1/2010

NCT02239484 Phase 1 COMPLETED

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Started: 3/1/2014

NCT02011633 Phase 1 COMPLETED

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg

Started: 10/1/2013

NCT02026817 Phase 1 COMPLETED

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg

Started: 12/1/2013

NCT01869985 Phase 1 COMPLETED

Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers

Started: 8/1/2013

NCT01929070 Phase 1 COMPLETED

A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

Started: 2/1/2013

NCT01030315 Phase 1 COMPLETED

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects

Started: 10/1/2009

NCT01455571 Phase 1 COMPLETED

Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors

Started: 11/1/2009

NCT01093729 Phase 1 COMPLETED

A Study of HM11260C in Healthy Male Subject

Started: 2/1/2010

NCT01037543 Phase 1 COMPLETED

Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects

Started: 11/1/2009

NCT01504581 Phase 1 COMPLETED

Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects

Started: 3/1/2011

NCT01093742 Phase 1 COMPLETED

A Study of HM10560A in Healthy Male Subject

Started: 3/1/2010

NCT00998283 Phase 1 COMPLETED

Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean Subjects

Started: 10/1/2009

NCT01013064 Phase 1 COMPLETED

A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects

Started: 11/1/2009

NCT01929512 Phase 1 COMPLETED

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

Started: 6/1/2013

NCT01775579 Phase 1 COMPLETED

Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium

Started: 1/1/2013

NCT01521455 Phase 1 COMPLETED

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Started: 2/1/2012

NCT01901757 Phase 1 COMPLETED

Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers

Started: 6/1/2013

NCT01651481 Phase 1 COMPLETED

Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination

Started: 7/1/2012

NCT01548157 Phase 1 COMPLETED

Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

Started: 3/1/2012

NCT01455584 Phase 1 COMPLETED

Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors

Started: 6/1/2011

NCT01555398 Phase 1 COMPLETED

Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule

Started: 2/1/2012

NCT01491503 Phase 1 COMPLETED

A Drug Interaction Study of Montelukast and Levocetirizine

Started: 11/1/2011

NCT00986843 Phase 1 COMPLETED

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)

Started: 6/1/2008

NCT01573663 Phase 1 COMPLETED

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

Started: 2/1/2012

NCT01447797 Phase 1 COMPLETED

A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Started: 9/1/2011

NCT01509196 Phase 1 COMPLETED

A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet

Started: 11/1/2011

NCT01448330 Phase 1 COMPLETED

A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

Started: 7/1/2011

NCT00979563 Phase 1 COMPLETED

Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies

Started: 7/1/2008

NCT01197014 Phase 1 COMPLETED

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Started: 9/1/2010

NCT01197001 Phase 1 COMPLETED

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Started: 8/1/2010

NCT00954304 Phase 1 COMPLETED

Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet

Started: 6/1/2009

NCT03666351 Phase 4 COMPLETED

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Started: 10/18/2018

NCT03110874 Phase 4 COMPLETED

Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control

Started: 10/8/2015

NCT01830491 Phase 4 COMPLETED

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

Started: 3/1/2009

NCT01828359 Phase 4 COMPLETED

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

Started: 8/1/2010

Drug Candidates

HM15275 Placebo of HM15275 BH3120 pembrolizumab Belvarafenib HM17321 Placebo of HM17321 HM11260C Placebo HIP2503
Activity Status: Active
Last Trial Started: 5/1/2026
Last Trial Ended: 6/18/2025
Trials (12 months): 6
Completed Trials: 139
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.